Eye Health Ingredients Market Size - By Ingredient, Form, Disease Indication, Source, End Use & Forecast, 2023

Description

List of Tables

Eye Health Ingredients Market is expected to register a 7.5% CAGR during 2023-2032, driven by rising consumer awareness, innovations in ingredient formulations, and rising incidence of eye conditions.

According to a report published by WHO in 2023, globally, over 2.2 billion people experience either near or distance vision impairment, with preventable or unaddressed cases affecting at least 1 billion individuals. As more individuals grapple with eye health issues, there is a growing awareness and recognition of the pivotal role that targeted ingredients play in promoting and maintaining ocular well-being. Moreover, the imperative need for solutions tailored to address specific eye health issues has further propelled the product demand.

The overall eye health ingredients industry is classified based on source, ingredient, end-use, form disease indication and region.

Beta carotene ingredient segment is anticipated to witness substantial demand through 2032 fuelled by its antioxidant properties and the ability to convert vitamin A in the body thereby promoting healthy vision. Moreover, as an essential precursor to retinol, beta carotene contributes to the maintenance of eye tissues and the prevention of age-related macular degeneration.

The animal end-use segment is poised for robust growth through 2032, driven by the growing recognition of pet health and the pivotal role of nutrition in sustaining their vision. The seamless integration of eye health ingredients into pet foods and supplements is anticipated to fuel a surge in specialized products, catering to the evolving needs of companion animals. Additionally, the rise of consumer awareness about the overall well-being of pets, including eye health, is expected to propel the product demand.

North America eye health ingredients industry share is expected to register swift gains during 2023-2032 driven by the region's health-conscious consumer base, advanced healthcare infrastructure, and increasing adoption of preventive health measures. As consumers in North America prioritize eye health and embrace nutritional supplements, the regional market will further expand.

Product Code: 1582

Chapter 1 Methodology & Scope

1.1 Methodology
- 1.1.1 Initial data exploration
- 1.1.2 Statistical model and forecast
- 1.1.3 Industry insights and validation
- 1.1.4 Definitions & forecast parameters
1.2 Data sources
- 1.2.1 Secondary
- 1.2.2 Primary

Chapter 2 Executive Summary

2.1 Eye health ingredients market 360 degree synopsis, 2018 -2032
- 2.1.1 Business trends
- 2.1.2 Source trends
- 2.1.3 Ingredient trends
- 2.1.4 Form trends
- 2.1.5 Application trends
- 2.1.6 Disease indication trends
- 2.1.7 Regional trends

Chapter 3 Eye Health Ingredients Industry Insights

3.1 Industry segmentation
3.2 Industry growth landscape, 2018 -2032
3.3 Industry ecosystem analysis
- 3.3.1 Regional profit margin trends
  - 3.3.1.1 North America
  - 3.3.1.2 Europe
  - 3.3.1.3 APAC
  - 3.3.1.4 LATAM
  - 3.3.1.5 MEA
- 3.3.2 Vendor matrix
  - 3.3.2.1 Raw material suppliers
  - 3.3.2.2 Ingredient manufacturers
  - 3.3.2.3 Geographical footprint
  - 3.3.2.4 Production capacity of key players
- 3.3.3 Distribution channel analysis
  - 3.3.3.1 Supermarkets
  - 3.3.3.2 Specialty retail
  - 3.3.3.3 Pharmacy Chains
  - 3.3.3.4 Independent Retailers
  - 3.3.3.5 Internet/ home shopping
3.4 Regional pricing trends
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 APAC
- 3.4.4 LATAM
- 3.4.5 MEA
3.5 Trade scenario
3.6 Regulatory landscape
- 3.6.1 Regulation of Color Additives
  - 3.6.1.1 U.S.
  - 3.6.1.2 Europe
  - 3.6.1.3 China
  - 3.6.1.4 APAC
3.7 Regional raw material trends
- 3.7.1 Lutein
- 3.7.2 Zeaxanthin
- 3.7.3 Beta Carotene
- 3.7.4 Vitamin A
- 3.7.5 Bilberry extracts
- 3.7.6 Others (Capsanthin, Annatto, Omega-3)
3.8 Industry impact forces
- 3.8.1 Growth drivers
  - 3.8.1.1 Increasing consumer concerns around eye health
  - 3.8.1.2 Nutraceutical industry expansion
  - 3.8.1.3 Increasing AMD disease occurrence among geriatric population
  - 3.8.1.4 Increase in healthcare expenditure leading consumer interest over OTC supplements
- 3.8.2 Industry pitfalls & challenges
  - 3.8.2.1 Limited availability of lutein and zeaxanthin
  - 3.8.2.2 Harmful health effects from carotenoid consumption
3.9 Eye health ingredients latest product launches
- 3.9.1 U.S.
- 3.9.2 Germany
- 3.9.3 Russia
- 3.9.4 India
- 3.9.5 UK
- 3.9.6 China
- 3.9.7 Brazil
- 3.9.8 South Africa
3.10 Growth potential analysis, 2022
3.11 Critical success factors
- 3.11.1 Role of industry associations
- 3.11.2 International demographics of declining vision
- 3.11.3 Consumer behavior towards eye health ingredients
- 3.11.4 OTC eye care supplements vs prescribed eyecare supplements
- 3.11.5 Regional consumer insights
  - 3.11.5.1 North America
  - 3.11.5.2 Europe
  - 3.11.5.3 APAC
  - 3.11.5.4 LATAM
  - 3.11.5.5 MEA
3.12 Porter's analysis
3.13 Company market share analysis, 2022
- 3.13.1 Strategy dashboard
3.14 PESTEL analysis

Chapter 4 Eye Health Ingredients Market, By Source

4.1 Global eye health ingredients market share by source, 2018 & 2032
4.2 Natural
- 4.2.1 Market estimates and forecast, 2018 -2032
- 4.2.2 Market estimates and forecast, by region, 2018-2032
4.3 Synthetic
- 4.3.1 Market estimates and forecast, 2018 -2032
- 4.3.2 Market estimates and forecast, by region, 2018-2032

Chapter 5 Eye Health Ingredients Market, By Ingredient

5.1 Global eye health ingredients market share by ingredient, 2018 & 2032
5.2 Lutein
- 5.2.1 Market estimates and forecast, 2018 -2032
- 5.2.2 Market estimates and forecast, by region, 2018-2032
5.3 Zeaxanthin
- 5.3.1 Market estimates and forecast, 2018 -2032
- 5.3.2 Market estimates and forecast, by region, 2018-2032
5.4 Beta Carotene
- 5.4.1 Market estimates and forecast, 2018 -2032
- 5.4.2 Market estimates and forecast, by region, 2018-2032
5.5 Vitamin A
- 5.5.1 Market estimates and forecast, 2018 -2032
- 5.5.2 Market estimates and forecast, by region, 2018-2032
5.6 Bilberry extracts
- 5.6.1 Market estimates and forecast, 2018 -2032
- 5.6.2 Market estimates and forecast, by region, 2018-2032
5.7 Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)
- 5.7.1 Market estimates and forecast, 2018 -2032
- 5.7.2 Market estimates and forecast, by region, 2018-2032

Chapter 6 Eye Health Ingredients Market, By Form

6.1 Global eye health ingredients market share by form, 2018 & 2032
6.2 Soft gel, capsule & tablets
- 6.2.1 Market estimates and forecast, 2018 -2032
- 6.2.2 Market estimates and forecast, by region, 2018-2032
6.3 Liquid
- 6.3.1 Market estimates and forecast, 2018 -2032
- 6.3.2 Market estimates and forecast, by region, 2018-2032
6.4 Powder
- 6.4.1 Market estimates and forecast, 2018 -2032
- 6.4.2 Market estimates and forecast, by region, 2018-2032

Chapter 7 Eye Health Ingredients Market, By Application

7.1 Global eye health ingredients market share by application, 2018 & 2032
7.2 Human
- 7.2.1 Market estimates and forecast, 2018 -2032
- 7.2.2 Market estimates and forecast, by region, 2018-2032
7.3 Animal
- 7.3.1 Market estimates and forecast, 2018 -2032
- 7.3.2 Market estimates and forecast, by region, 2018-2032

Chapter 8 Eye Health Ingredients Market, By Disease Indication

8.1 Global eye health ingredients market share by disease indication, 2018 & 2032
8.2 Age related macular degeneration
- 8.2.1 Market estimates and forecast, 2018 -2032
- 8.2.2 Market estimates and forecast, by region, 2018-2032
8.3 Cataract
- 8.3.1 Market estimates and forecast, 2018 -2032
- 8.3.2 Market estimates and forecast, by region, 2018-2032
8.4 Dry eye syndrome
- 8.4.1 Market estimates and forecast, 2018 -2032
- 8.4.2 Market estimates and forecast, by region, 2018-2032
8.5 Other indications
- 8.5.1 Market estimates and forecast, 2018 -2032
- 8.5.2 Market estimates and forecast, by region, 2018-2032

Chapter 9 Eye Health Ingredients Market, By Region

9.1 Global eye health ingredients market share by region, 2018 & 2032
9.2 North America
- 9.2.1 Market estimates and forecast, 2018 - 2032
- 9.2.2 Market estimates and forecast, by source, 2018 - 2032
- 9.2.3 Market estimates and forecast, by ingredient, 2018 - 2032
- 9.2.4 Market estimates and forecast, by form, 2018 - 2032
- 9.2.5 Market estimates and forecast, by application, 2018 - 2032
- 9.2.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.2.7 U.S.
  - 9.2.7.1 Market estimates and forecast, 2018 - 2032
  - 9.2.7.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.2.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.2.7.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.2.7.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.2.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.2.8 Canada
  - 9.2.8.1 Market estimates and forecast, 2018 - 2032
  - 9.2.8.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.2.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.2.8.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.2.8.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.2.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
9.3 Europe
- 9.3.1 Market estimates and forecast, 2018 - 2032
- 9.3.2 Market estimates and forecast, by source, 2018 - 2032
- 9.3.3 Market estimates and forecast, by ingredient, 2018 - 2032
- 9.3.4 Market estimates and forecast, by form, 2018 - 2032
- 9.3.5 Market estimates and forecast, by application, 2018 - 2032
- 9.3.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.3.7 Germany
  - 9.3.7.1 Market estimates and forecast, 2018 - 2032
  - 9.3.7.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.3.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.3.7.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.3.7.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.3.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.3.8 UK
  - 9.3.8.1 Market estimates and forecast, 2018 - 2032
  - 9.3.8.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.3.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.3.8.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.3.8.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.3.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.3.9 France
  - 9.3.9.1 Market estimates and forecast, 2018 - 2032
  - 9.3.9.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.3.9.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.3.9.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.3.9.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.3.9.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.3.10 Italy
  - 9.3.10.1 Market estimates and forecast, 2018 - 2032
  - 9.3.10.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.3.10.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.3.10.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.3.10.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.3.10.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.3.11 Russia
  - 9.3.11.1 Market estimates and forecast, 2018 - 2032
  - 9.3.11.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.3.11.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.3.11.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.3.11.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.3.11.6 Market estimates and forecast, by disease indication, 2018 - 2032
9.4 Asia Pacific
- 9.4.1 Market estimates and forecast, 2018 - 2032
- 9.4.2 Market estimates and forecast, by source, 2018 - 2032
- 9.4.3 Market estimates and forecast, by ingredient, 2018 - 2032
- 9.4.4 Market estimates and forecast, by form, 2018 - 2032
- 9.4.5 Market estimates and forecast, by application, 2018 - 2032
- 9.4.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.4.7 China
  - 9.4.7.1 Market estimates and forecast, 2018 - 2032
  - 9.4.7.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.4.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.4.7.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.4.7.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.4.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.4.8 India
  - 9.4.8.1 Market estimates and forecast, 2018 - 2032
  - 9.4.8.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.4.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.4.8.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.4.8.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.4.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.4.9 South Korea
  - 9.4.9.1 Market estimates and forecast, 2018 - 2032
  - 9.4.9.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.4.9.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.4.9.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.4.9.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.4.9.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.4.10 Japan
  - 9.4.10.1 Market estimates and forecast, 2018 - 2032
  - 9.4.10.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.4.10.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.4.10.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.4.10.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.4.10.6 Market estimates and forecast, by disease indication, 2018 - 2032
9.5 Latin America
- 9.5.1 Market estimates and forecast, 2018 - 2032
- 9.5.2 Market estimates and forecast, by source, 2018 - 2032
- 9.5.3 Market estimates and forecast, by ingredient, 2018 - 2032
- 9.5.4 Market estimates and forecast, by form, 2018 - 2032
- 9.5.5 Market estimates and forecast, by application, 2018 - 2032
- 9.5.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.5.7 Brazil
  - 9.5.7.1 Market estimates and forecast, 2018 - 2032
  - 9.5.7.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.5.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.5.7.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.5.7.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.5.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.5.8 Mexico
  - 9.5.8.1 Market estimates and forecast, 2018 - 2032
  - 9.5.8.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.5.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.5.8.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.5.8.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.5.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.5.9 Argentina
  - 9.5.9.1 Market estimates and forecast, 2018 - 2032
  - 9.5.9.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.5.9.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.5.9.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.5.9.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.5.9.6 Market estimates and forecast, by disease indication, 2018 - 2032
9.6 Middle East & Africa (MEA)
- 9.6.1 Market estimates and forecast, 2018 - 2032
- 9.6.2 Market estimates and forecast, by source, 2018 - 2032
- 9.6.3 Market estimates and forecast, by ingredient, 2018 - 2032
- 9.6.4 Market estimates and forecast, by form, 2018 - 2032
- 9.6.5 Market estimates and forecast, by application, 2018 - 2032
- 9.6.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.6.7 Saudi Arabia
  - 9.6.7.1 Market estimates and forecast, 2018 - 2032
  - 9.6.7.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.6.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.6.7.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.6.7.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.6.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.6.8 UAE
  - 9.6.8.1 Market estimates and forecast, 2018 - 2032
  - 9.6.8.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.6.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.6.8.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.6.8.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.6.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
- 9.6.9 South Africa
  - 9.6.9.1 Market estimates and forecast, 2018 - 2032
  - 9.6.9.2 Market estimates and forecast, by source, 2018 - 2032
  - 9.6.9.3 Market estimates and forecast, by ingredient, 2018 - 2032
  - 9.6.9.4 Market estimates and forecast, by form, 2018 - 2032
  - 9.6.9.5 Market estimates and forecast, by application, 2018 - 2032
  - 9.6.9.6 Market estimates and forecast, by disease indication, 2018 - 2032

Chapter 10 Company Profiles

10.1 Allied Biotech Corporation
- 10.1.1 Business Overview
- 10.1.2 Financial Data
- 10.1.3 Concentrations Landscape
- 10.1.4 Strategic Outlook
- 10.1.5 SWOT Analysis
10.2 BASF
- 10.2.1 Business Overview
- 10.2.2 Financial Data
- 10.2.3 Concentrations Landscape
- 10.2.4 Strategic Outlook
- 10.2.5 SWOT Analysis
10.3 DSM
- 10.3.1 Business Overview
- 10.3.2 Financial Data
- 10.3.3 Concentrations Landscape
- 10.3.4 Strategic Outlook
- 10.3.5 SWOT Analysis
10.4 Kemin
- 10.4.1 Business Overview
- 10.4.2 Financial Data
- 10.4.3 Concentrations Landscape
- 10.4.4 Strategic Outlook
- 10.4.5 SWOT Analysis
10.5 Tianjin Pharmaland Technology
- 10.5.1 Business Overview
- 10.5.2 Financial Data
- 10.5.3 Concentrations Landscape
- 10.5.4 Strategic Outlook
- 10.5.5 SWOT Analysis
10.6 American River Nutrition, Inc
- 10.6.1 Business Overview
- 10.6.2 Financial Data
- 10.6.3 Concentrations Landscape
- 10.6.4 Strategic Outlook
- 10.6.5 SWOT Analysis
10.7 Archer Daniels Midland Company
- 10.7.1 Business Overview
- 10.7.2 Financial Data
- 10.7.3 Concentrations Landscape
- 10.7.4 Strategic Outlook
- 10.7.5 SWOT Analysis
10.8 Vitae Naturals
- 10.8.1 Business Overview
- 10.8.2 Financial Data
- 10.8.3 Concentrations Landscape
- 10.8.4 Strategic Outlook
- 10.8.5 SWOT Analysis
10.9 Davos life Science
- 10.9.1 Business Overview
- 10.9.2 Financial Data
- 10.9.3 Concentrations Landscape
- 10.9.4 Strategic Outlook
- 10.9.5 SWOT Analysis
10.10 Cargil
- 10.10.1 Business Overview
- 10.10.2 Financial Data
- 10.10.3 Concentrations Landscape
- 10.10.4 Strategic Outlook
- 10.10.5 SWOT Analysis
10.11 Wilmer Spring Fruit Nutrition Products Co. Ltd
- 10.11.1 Business Overview
- 10.11.2 Financial Data
- 10.11.3 Concentrations Landscape
- 10.11.4 Strategic Outlook
- 10.11.5 SWOT Analysis
10.12 FMC corporation
- 10.12.1 Business Overview
- 10.12.2 Financial Data
- 10.12.3 Concentrations Landscape
- 10.12.4 Strategic Outlook
- 10.12.5 SWOT Analysis
10.13 Vidya Europe SAS
- 10.13.1 Business Overview
- 10.13.2 Financial Data
- 10.13.3 Concentrations Landscape
- 10.13.4 Strategic Outlook
- 10.13.5 SWOT Analysis

Chapter 11 Potential Customer Profiles

11.1 Amway
- 11.1.1 Business Overview
- 11.1.2 Financial Data
- 11.1.3 Concentrations Landscape
- 11.1.4 Strategic Outlook
11.2 Solgar
- 11.2.1 Business Overview
- 11.2.2 Financial Data
- 11.2.3 Concentrations Landscape
- 11.2.4 Strategic Outlook
11.3 Life extension
- 11.3.1 Business Overview
- 11.3.2 Financial Data
- 11.3.3 Concentrations Landscape
- 11.3.4 Strategic Outlook
11.4 Jarrow Formulas
- 11.4.1 Business Overview
- 11.4.2 Financial Data
- 11.4.3 Concentrations Landscape
- 11.4.4 Strategic Outlook
11.5 NOW Foods
- 11.5.1 Business Overview
- 11.5.2 Financial Data
- 11.5.3 Concentrations Landscape
- 11.5.4 Strategic Outlook
11.6 Natures's Life
- 11.6.1 Business Overview
- 11.6.2 Financial Data
- 11.6.3 Concentrations Landscape
- 11.6.4 Strategic Outlook
11.7 Nutrovea
- 11.7.1 Business Overview
- 11.7.2 Financial Data
- 11.7.3 Concentrations Landscape
- 11.7.4 Strategic Outlook
11.8 Natures Lab
- 11.8.1 Business Overview
- 11.8.2 Financial Data
- 11.8.3 Concentrations Landscape
- 11.8.4 Strategic Outlook
11.9 Zenith Nutrition
- 11.9.1 Business Overview
- 11.9.2 Financial Data
- 11.9.3 Concentrations Landscape
- 11.9.4 Strategic Outlook
11.10 Blubonnet Nutrition
- 11.10.1 Business Overview
- 11.10.2 Financial Data
- 11.10.3 Concentrations Landscape
- 11.10.4 Strategic Outlook
11.11 Sirulina
- 11.11.1 Business Overview
- 11.11.2 Financial Data
- 11.11.3 Concentrations Landscape
- 11.11.4 Strategic Outlook
11.12 Caps Extra
- 11.12.1 Business Overview
- 11.12.2 Financial Data
- 11.12.3 Concentrations Landscape
- 11.12.4 Strategic Outlook
11.13 MacuShield
- 11.13.1 Business Overview
- 11.13.2 Financial Data
- 11.13.3 Concentrations Landscape
- 11.13.4 Strategic Outlook
11.14 PreserVision
- 11.14.1 Business Overview
- 11.14.2 Financial Data
- 11.14.3 Concentrations Landscape
- 11.14.4 Strategic Outlook
11.15 Efalex
- 11.15.1 Business Overview
- 11.15.2 Financial Data
- 11.15.3 Concentrations Landscape
- 11.15.4 Strategic Outlook
11.16 BioCare NutriGuard
- 11.16.1 Business Overview
- 11.16.2 Financial Data
- 11.16.3 Concentrations Landscape
- 11.16.4 Strategic Outlook
11.17 Futurebiotics
- 11.17.1 Business Overview
- 11.17.2 Financial Data
- 11.17.3 Concentrations Landscape
- 11.17.4 Strategic Outlook
11.18 Swanson Products
- 11.18.1 Business Overview
- 11.18.2 Financial Data
- 11.18.3 Concentrations Landscape
- 11.18.4 Strategic Outlook
11.19 Davis Vision
- 11.19.1 Business Overview
- 11.19.2 Financial Data
- 11.19.3 Concentrations Landscape
- 11.19.4 Strategic Outlook
11.20 Alcon
- 11.20.1 Business Overview
- 11.20.2 Financial Data
- 11.20.3 Concentrations Landscape
- 11.20.4 Strategic Outlook
11.21 Pfizer Inc.
- 11.21.1 Business Overview
- 11.21.2 Financial Data
- 11.21.3 Concentrations Landscape
- 11.21.4 Strategic Outlook
11.22 Vitabiotics Ltd.
- 11.22.1 Business Overview
- 11.22.2 Financial Data
- 11.22.3 Concentrations Landscape
- 11.22.4 Strategic Outlook
11.23 Valeant Pharmaceuticals International Inc.
- 11.23.1 Business Overview
- 11.23.2 Financial Data
- 11.23.3 Concentrations Landscape
- 11.23.4 Strategic Outlook
11.24 Alliance Pharma
- 11.24.1 Business Overview
- 11.24.2 Financial Data
- 11.24.3 Concentrations Landscape
- 11.24.4 Strategic Outlook
11.25 The Nature's Bounty Co
- 11.25.1 Business Overview
- 11.25.2 Financial Data
- 11.25.3 Concentrations Landscape
- 11.25.4 Strategic Outlook
11.26 Novartis AG
- 11.26.1 Business Overview
- 11.26.2 Financial Data
- 11.26.3 Concentrations Landscape
- 11.26.4 Strategic Outlook